ApprovalTrail

Drug · DIN 02457504

TARO-CAPECITABINE

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since August 31, 2017; first marketed August 31, 2017.
Drug Identification Number (DIN)
02457504
Company (DIN owner)
Taro Pharmaceuticals IncBrampton, Ontario, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Capecitabine L01BC06
Class
Human
Record last updated
May 28, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
CAPECITABINE500 MG

Notices of Compliance

Health Canada approvals that name this DIN.

Other DINs named TARO-CAPECITABINE